Screening for insulin resistance in polycystic ovary syndrome: Views of physician members of the american society for reproductive medicine

OBJECTIVE: To determine practice patterns for insulin resistance (IR) evaluation and management in women with polycystic ovary syndrome (PCOS) among physician members of the American Society for Reproductive Medicine (ASRM). STUDY DESIGN: Crosssectional survey using a web-based questionnaire. RESULTS: A total of 205 members responded. Respondents were board-certified (94%), or board-eligible (6%), in obstetrics and gynecology. Sixty-four percent of the respondents use the Rotterdam 2003 Criteria for a diagnosis of PCOS. Two-thirds (68%) screen for IR in women with PCOS. Respondents who screen for IR were more likely to also screen for diabetes and impaired glucose tolerance (OR 3.37, 95% CI 1.48–7.21). The 2-hour oral glucose tolerance test with glucose and insulin concentrations was the most common IR screening test used (45%). Metformin therapy was used by 33% of respondents for “all women with PCOS who have IR.” The majority (68%) responded that there is a need for a committee opinion from ASRM on IR testing in PCOS. CONCLUSION: Two-thirds of ASRM physician members surveyed screen women with PCOS for IR in spite of the lack of general consensus on the need for such screening from endocrine societies.